APT Medical Inc.

SHSE:688617 Stock Report

Market Cap: CN¥34.8b

APT Medical Future Growth

Future criteria checks 6/6

APT Medical is forecast to grow earnings and revenue by 27.7% and 27.3% per annum respectively. EPS is expected to grow by 24.6% per annum. Return on equity is forecast to be 28.2% in 3 years.

Key information

27.7%

Earnings growth rate

24.6%

EPS growth rate

Medical Equipment earnings growth22.6%
Revenue growth rate27.3%
Future return on equity28.2%
Analyst coverage

Low

Last updated26 Jun 2024

Recent future growth updates

Recent updates

More Unpleasant Surprises Could Be In Store For APT Medical Inc.'s (SHSE:688617) Shares After Tumbling 27%

Jul 25
More Unpleasant Surprises Could Be In Store For APT Medical Inc.'s (SHSE:688617) Shares After Tumbling 27%

APT Medical (SHSE:688617) Is Very Good At Capital Allocation

Jul 16
APT Medical (SHSE:688617) Is Very Good At Capital Allocation

Are APT Medical Inc. (SHSE:688617) Investors Paying Above The Intrinsic Value?

Jun 20
Are APT Medical Inc. (SHSE:688617) Investors Paying Above The Intrinsic Value?

APT Medical Inc. (SHSE:688617) Stock Rockets 28% As Investors Are Less Pessimistic Than Expected

May 10
APT Medical Inc. (SHSE:688617) Stock Rockets 28% As Investors Are Less Pessimistic Than Expected

APT Medical's (SHSE:688617) Promising Earnings May Rest On Soft Foundations

May 02
APT Medical's (SHSE:688617) Promising Earnings May Rest On Soft Foundations

APT Medical (SHSE:688617) Knows How To Allocate Capital Effectively

Apr 10
APT Medical (SHSE:688617) Knows How To Allocate Capital Effectively

Here's Why We Think APT Medical (SHSE:688617) Might Deserve Your Attention Today

Mar 19
Here's Why We Think APT Medical (SHSE:688617) Might Deserve Your Attention Today

Earnings and Revenue Growth Forecasts

SHSE:688617 - Analysts future estimates and past financials data (CNY Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/20263,7761,240N/A9483
12/31/20252,951951N/A1,1075
12/31/20242,200703N/A5904
3/31/20241,756571389687N/A
12/31/20231,650534487689N/A
9/30/20231,542501404572N/A
6/30/20231,448457352519N/A
3/31/20231,300394267417N/A
12/31/20221,216358224367N/A
9/30/20221,123306197371N/A
6/30/20221,000252103250N/A
3/31/202293322840206N/A
12/31/202182920814181N/A
9/30/202175020139164N/A
6/30/2021671186119223N/A
3/31/2021569149139200N/A
12/31/2020479111104148N/A
9/30/20204429361110N/A
12/31/201940483-1355N/A
12/31/201824222-1419N/A
12/31/201715334N/A13N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: 688617's forecast earnings growth (27.7% per year) is above the savings rate (2.9%).

Earnings vs Market: 688617's earnings (27.7% per year) are forecast to grow faster than the CN market (21.8% per year).

High Growth Earnings: 688617's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: 688617's revenue (27.3% per year) is forecast to grow faster than the CN market (13.4% per year).

High Growth Revenue: 688617's revenue (27.3% per year) is forecast to grow faster than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: 688617's Return on Equity is forecast to be high in 3 years time (28.2%)

Discover growth companies

7D

1Y

7D

1Y

7D

1Y